Core Viewpoint - 康健国际医疗 (03886) expects to achieve an unaudited consolidated profit of approximately HKD 25.2 million to HKD 39.6 million for the six months ending June 30, 2025, a significant turnaround from an unaudited consolidated loss of approximately HKD 28.5 million for the six months ending June 30, 2024 [1] Financial Performance - The expected unaudited profit includes an estimated unaudited profit attributable to shareholders of approximately HKD 9.1 million to HKD 14.3 million [1] - The previous period (ending June 30, 2024) recorded an unaudited loss attributable to shareholders of approximately HKD 47.7 million [1] Factors Influencing Performance - The turnaround from loss to profit is primarily due to several factors: - The fair value loss of the group's investment properties for the six months ending June 30, 2025, decreased compared to the same period in 2024 [1] - No impairment loss was recorded for the group's interests in joint ventures for the six months ending June 30, 2025, whereas an impairment loss was recorded for the same period in 2024 [1] - The group recognized a profit from its share of joint ventures for the six months ending June 30, 2025, compared to a loss for the same period in 2024 [1] - The group's gross profit for the six months ending June 30, 2025, decreased compared to the same period in 2024 [1]
康健国际医疗(03886)发盈喜，预期中期未经审核综合溢利约2520万港元至3960万港元